OBJECTIVES: Recent studies have suggested that postoperative complications could have a potential negative effect on long-term outcome after oesophagectomy for cancer. Because respiratory failures represent the most frequent postoperative complication, we have investigated the prognostic impact of these complications on disease-free survival (DFS).
INTRODUCTION
Postoperative respiratory complications after oesophagectomy for cancer still remain the most common adverse events, and constitute the main leading cause of postoperative death [1] [2] [3] [4] [5] [6] [7] . Many studies have investigated the pathophysiology of these respiratory complications. A major obstacle to a comprehensive analysis of these critical problems is the lack of standardized definitions of respiratory complications, which hinders comparisons of incidence rates across studies. Respiratory complications have been recognized in recent years as directly influencing not only postoperative mortality, but also long-term survival [8, 9] . More generally, the overall postoperative complications are presumed to lead to a strong impairment of the immunological system that may adversely impact on the oncological outcome. As a result, a link has been suggested between a poor postoperative outcome and the early recurrence of the disease and its timing [10] [11] [12] . Our group suggested such a link in the subgroup of patients with oesophageal adenocarcinoma in the late 1990s [13] . However, these findings should be assessed with caution as they reflect multiple confounding factors and several statistical artefacts. From an oncological point of view, investigations on the outcome should be mainly based on disease-free survival (DFS) rather survival alone in order to express the cancer-specific outcome. Obviously, investigation on long-term survival should exclude in-hospital mortality.
We thus tested the hypothesis that respiratory complications per se could have a negative prognostic impact on cancerspecific survival.
PATIENTS AND METHODS

Patient's demographics
The national review board of the French Society of Thoracic and Cardiovascular Surgery (FSTCVS) assessed the design of this study (n°2011-8-7-16-6-10-D2Th). Because of its retrospective nature, the IRB waived the need for patient consent.
From a prospective single-institution database, 405 patients having undergone a curative transthoracic oesophagectomy with a two-field lymphadenectomy and gastric reconstruction from 1996 to 2010 were identified retrospectively. Among the initial cohort, 21 patients (5%) were excluded from the final analysis because of an incomplete R1-R2 resection. The remaining 384 patients constituted a homogeneous group of R0 patients with a standardized and curative surgery. However, in order to be free from the confounding effect of the 90-day mortality on the survival assessment, we have specifically focused on the remaining 341 patients after exclusion of the 43 patients (11%) who died within 90 days postoperatively.
Preoperative work-up
All patients were clinically staged on the basis of an oesogastroscopy, chest and abdominal CT-scan, and routine endoscopic ultrasonography findings. Positron emission tomography computerized tomography (PET-CT) has been available since 2005 in our institution and has been routinely performed since this date. All operative procedures were performed with a curative intent. Patient with locally advanced tumours or distant metastasis considered as unresectable were medically treated with chemotherapy and radiation therapy.
Operative procedure overview
The surgical procedure consisted in all cases of a gastric tubulization to substitute the removed oesophagus. Location of the anastomosis was in the chest or in the neck depending on the location of the tumour. For adenocarcinoma below the carina, an intrathoracic anastomosis was performed. For squamous cell carcinoma or for long Barrett's oesophagus, a cervical anastomosis was preferred. The surgical procedure in all cases consists of a single-stage operation including an abdominal and a transthoracic approach resulting in a transthoracic oesophagectomy with radical two-field lymphadenectomy. An Ivor-Lewis procedure associated a midline laparotomy and a right thoracotomy with an anastomosis in the chest above the azygos vein. A left thoraco-abdominal approach consisted of a single left thoracoabdominal approach with an intra thoracic anastomosis below the aortic arch. The intrathoracic anastomosis was performed with a circular stapler. A McKeown procedure included first a right thoracotomy followed by a laparotomy and a left cervicotomy with a hand sewn cervical anastomosis. The resected specimen was carefully palpated by the pathologist. The clinical and pathological stages were classified according to the 2002 AJCC classification [14] . The use of thoracic epidural analgesia (TEA) for postoperative analgesia was systematically proposed in the absence of contraindications. In case of patient's refusal or thoracic epidural failure, thoracic paravertebral blockade analgesia or systemic opiate analgesia was planned.
Definition of complications
Patients who did not experience postoperative complications formed the group A. Patients who experienced respiratory complications defined as follows formed the group B. Respiratory complications were defined as any medical events concerning the lung parenchyma, i.e. atelectasis, pneumonia and acute respiratory distress syndrome (ARDS), having occurred in the absence of early surgical complications. Atelectasis was considered when bronchoscopic aspiration or non-invasive ventilation was required but without clinical signs of infection (fever <38.5°, white blood cell count <12 × 10 3 /ml). Pneumonia was defined as appearence of a new pulmonary infiltrate on chest X-ray associated with positive bacterial culture of the sputum or presence of pulmonary infiltrates with fever (temperature >38.5°C) and a white blood cell count >12 × 10 3 /ml. In patients receiving mechanical ventilation, the diagnosis of pneumonia was confirmed by a culture of broncho-alveolar lavage >10 4 c.f.u./ml. ARDS was defined by acute bilateral lung infiltrates on chest X-ray, a PaO 2 / FiO 2 ratio <200 mmHg with a pulmonary pressure <18 mmHg.
Other complications were classified as medical and surgical complications and formed the group C. All patients who presented with respiratory complications associated with a surgical complication were included in this group. Surgical complications included anastomotic leakage, laryngeal paralysis, chylothorax, pleural effusion requiring chest tube drainage, empyoema, bleeding, mediastinitis, intestinal occlusion and the need for re-intervention. Medical complication included myocardial infarction, deep venous thrombosis, cardiac failure, arrhythmia, pulmonary embolism, sepsis, renal and hepatic failure.
All postoperative complications were graded according to the modified Clavien classification [15] : grade 0: no complication, grade 1: any deviation from the normal postoperative course without the need for pharmacological treatment, grade 2: deviation from the normal postoperative course requiring pharmacological treatment, grade 3: deviation from the normal postoperative course requiring surgical, endoscopic or radiological intervention and grade 4: any life-threatening complication requiring intensive care management.
Follow-up and recurrences
All patients were followed at the outpatient clinic 1 month after discharge, then every 3 months during the first 2 years and every 6 months thereafter. A physical examination, a nutritional assessment and a chest X-ray were routinely performed. A CT-scan combined with an endoscopic examination every 6 months assessed recurrences. In case of a suspicion of recurrence, every effort was made to obtain a pathological specimen using several techniques (i.e. EBUS-NA, EUS-NA or biopsy). In case of a normal work-up, the patients were considered as free of disease. The last follow-up was made in December 2010, which constituted the last censoring date.
Statistical analysis
Statistical analysis was performed using the SPSS software version 12.0 (Statistical Package for the Social Sciences, Chicago, IL, USA). Survival and DFS rates were calculated from the date of operation to the time of death or recurrence, respectively. Survival curves presented two models: one including postoperative mortality and the other excluding 90-day mortality. Survival and DFS curves were estimated by the Kaplan-Meier method. Comparisons between subgroups were based on the log-rank test to determine significance.
A logistic regression analysis was conducted to discriminate predictive factors affecting DFS. Variables to consider in the multivariate analysis were obtained from the univariate analysis. All variables with a P-value <0.1 were introduced in the Cox regression model. P < 0.05 was considered statistically significant. Table 1 summarizes the characteristics of the 341 patients included in the study. The mean age of the cohort was 60 0.1 ± 10 years (range: 18-83). There were 55 women (16%) and 286 men (84%). Adenocarcinoma represented 62% of the total cohort and Barrett's metaplasia was found in 82 patients (25%). Half of the patients underwent neoadjuvant chemoradiotherapy prior to surgery (n = 179, 51%). Neoadjuvant therapy was proposed for locally advanced oesophageal cancer (T3-T4 and/or N+ patients). The majority of patients received concomitant chemoradiotherapy regimen based on 5-fluorouracyl-cisplatin and 45 Gy of radiotherapy. Complete response (pT0N0) at final pathological examination was found in 37 patients (20%).
RESULTS
Patient characteristics
Postoperative complications
Of the 341 patients, 107 patients (31%) developed at least one postoperative pulmonary complication. Distribution is presented in Table 2 : there were 67 atelectasis (20%), 78 cases of pneumonia (23%) and 24 cases of ARDS (7%). Half of them (n = 45) required a management in the intensive care unit, one-third required a tracheostomy (n = 39), two-thirds required the use of non-invasive ventilation (n = 74) and half of them bronchoscopic aspiration. According to the modified Clavien classification, postoperative complications rates were as follows: grade 0: n = 147 (44%); grade 1: n = 7 (2%); grade 2: n = 56 (16%); grade 3: n = 69 (20%) and grade 4: n = 62 (18%).
Disease-free survival with exclusion of 90-day mortality.
Five-year DFS excluding the 90-day mortality rate was calculated according to the type of complications (Fig. 1) . In the group A including patients without postoperative complications, the 5-year DFS rate was 38%. In the group of respiratory complications (B), 5-year survival rate was 47%. In the group of other complications (group C), including medical and/or surgical complications, the 5-year survival rate was 55%. There were no significant differences between group A and B, and group A and C (P = 0.75 and P = 0.90, respectively). According to the modified Clavien classification, the DFS curves are presented in Fig. 2 . Five-year DFS rates were not significantly different between grade 0 (no complication, 38%, n = 147) and other grades (grade 1, 2, 3 and 4 (64, 45, 56 and 48%, respectively)).
Survival and disease-free survival including 90-day mortality. To demonstrate the statistical effect of the inclusion of the 90-day mortality on the outcome, we have investigated the survival and the DFS of the entire cohort (384 R0 patients) with inclusion of the 90-day mortality.
The 5-year DFS rate including the postoperative mortality rate and including the total cohort of R0 patients (n = 384) is provided in Fig. 3 . Five-year DFS rates were 39% (mean: 59 months, 95% CI: 50-68), 43% (mean: 50 months, 95% CI: 49-72) and 50% (mean: 52 months, 95% CI: 54-67) in the group A, B and C, respectively. There were no significant difference between the group A and B and the group A and C (P = 0.1 and P = 0.34, respectively).
The overall 5-year survival rate including the postoperative mortality rate and including the total cohort of R0 patients (n = 384) is provided in Fig. 4 . Five-year overall survival rates were 55% (mean: 76 months, 95% CI: 66-85), 49% (mean: 74 months, 95% CI: 61-86) and 61% (mean: 76 months, 95% CI: 66-87), in group A, B and C, respectively. They were statistically significant differences between group A and B (P = 0.013) but not between group A and C (P = 0.220).
Prognostic factors affecting DFS
To discriminate factors affecting DFS with exclusion of 90-day mortality, we have conducted a univariate analysis including eight variables: gender, histology, neoadjuvant chemoradiotherapy, clinical T-stage, clinical N-stage, extracapsular lymph node involvement, respiratory complications, Clavien classification. Table 3 summarizes the 5-year DFS for each variable. Variables with P-value <0.1 were included in a stepwise Cox regression model. Clavien classification and respiratory complications did not seem to influence the DFS and were not included in the multivariate analysis. At the final step of the logistic regression, only three variables were considered as independent factors affecting DFS: clinical T-stage, clinical N-stage and existence of an extracapsular lymph node involvement (Table 4 ). 
DISCUSSION
Postoperative patient-related variables as independent factors affecting survival have been scarcely suggested [9] [10] [11] [12] . During the postoperative period, several side effects of oesophagectomy can merge (e.g: surgical stress, impaired inflammatory response, malnutrition and reflux) [4, [16] [17] [18] [19] [20] . The expected end-results of this multifaceted process can lead to a strong impairment of the immunological system that may adversely impact on the oncological outcome [10, 11] . However, because of conflicting results, the conclusions that can be reached remain controversial. To put our study in better context of the existing literature, we briefly review here several studies that have examined the effect of the postoperative complications on outcomes.
Kinagusa was the first to suggest a potential negative prognostic impact of postoperative respiratory complications [8] . Five-year overall survival rate (26.7%) of 38 patients who developed pneumonia was significantly worse than 53.4% who did not. Multivariate analysis for overall survival showed that the pathological tumour stage and pneumonia were independent risk prognosticators. These results were confirmed by Abou-Jawde who has also reported that acute respiratory failure could have a negative impact on survival [9] . Behind respiratory complications, severe overall postoperative morbidity can be seen as potential negative pronosticators. Rizk et al. showed on a cohort of 510 patients that technical complications had a large negative impact on survival, but despite a strong relation between technical complications and medical complications, the study concluded that medical complication alone had a nonsignificant impact on overall survival [12] . In their analysis of 439 patients to identify the predictive factor of recurrence following complete resection, Mariette et al. [21] assessed the impact of pulmonary complications and other frequent postoperative complications on survival. However, postoperative complications appeared to have no impact on long-term survival. Lagarde et al. in their cohort of 351 patients found that the relation between peri-operative complications and cancer recurrence per se was not causal [10] . However, postoperative complications were independently associated with the early timing of death due to cancer recurrence. A possible explanation for this phenomenon was that immunological host factors enhance microscopic residual disease to develop more rapidly into clinically manifest recurrence. This result was supported by Ancona et al. in their analysis of 522 patients, concluding that surgical or medical complications did not affect survival rates, but when associated, the survival rate was substantially worse [20] . At last, Lerut et al. found in 150 consecutive patients a probable correlation between complications and early recurrence and its timing [11] .
In contrast to previous reports, our results suggest that when 90-day mortality has been excluded, postoperative respiratory complications do not seem to influence the long-term DFS. Our results could be explained by four factors that lead to these discrepancies.
The first factor stands on the definition of the postoperative complications, and more specifically on respiratory complications. Postoperative complications should be analysed separately, by categories to express a coherent pathogenic specific pathway rather than a grading system, such Clavien classification [15] . To date, despite this common and accepted classification, there is no standardized and global classification of the postoperative respiratory complications. For instance, Law et al. reported a 16% rate of major pulmonary complications including pneumonia and respiratory failure [22] . In constrast, Ferguson et al. [4] in their definition of pulmonary complications included the need for re-intubation for respiratory insufficiency or pneumonia, and found a 38% rate of major pulmonary complications. In this respect, the modified Clavien classification using different welldefined grades of severity is a valuable tool that enables objective and detailed documentation of postoperative complications, allowing a uniform and reproducible approach for a comprehensive surgical outcome assessment. Rather than reporting an overall rate for a given type of complication, it will reflect the severity of this complication. However, Clavien classification does not take into account the broad spectrum of the respiratory complications. The impact of the modified Clavien grading system on cancer-specific survival has been assessed by Lerut et al. [11] . A statistically significant relation was found between grade 2 and grade 3 but not between grade 2, 3 and 4. Because of the clinical heterogeneity of respiratory complications, investigation on the outcome only based on the Clavien grading system seems to hinder the real impact on the outcome. The second factor stands on the basis that the majority of previous studies have investigated on the impact of postoperative complications on overall survival. This is likely to underestimate the oncological effect of such immunosuppressive events on cancer-specific survival. For this reason, we have voluntary investigated the impact of respiratory complications on DFS. As Lerut et al. pointed out, if survival assessment suggests a possible impact of complications on oncological outcome, it seems more logical to focus on the occurrence of recurrent disease rather than on overall survival, which merges cancer-related and cancer-unrelated deaths [11] .
The third factor is supported by the fact that previous studies have included macroscopically and/or microscopically incomplete resection in their cohort. Lagarde [10] [11] [12] 23] . The aim of any oncological surgery is to achieve a complete resection (R0). As a result, we have excluded from our analysis, all R1-R2 incomplete resection in order to be free from this strong and well-known negative prognosticator on cancer-related outcome.
The fourth and last factor is the exclusion of the postoperative mortality. We have voluntarily opted to exclude those patients who died within the first postoperative 90 days because one can presume that the cause of death is in the vast majority of the cases related to the postoperative complications and their sequels, provided that an adequate preoperative work-up has been done. As shown in Figs 1 and 3 , exclusion of the 90-day mortality had a strong impact on the assessment of the overall and cancer-specific survivals. Moreover, respiratory complications were the leading cause of death after oesophagectomy, and thereby acted as a confounding prognosticator.
We acknowledge that this exploratory study has two main limitations. First, the three groups of patients submitted for comparison remain small (107, 147 and 87 patients). This is likely to lead to a type II error, wrongly finding no significant differences as differences still exist. Our study seems to be not powered enough to achieve definitive conclusions. However, this bias is inherent to every monocentric retrospective report. A large multicentric prospective study should be more adapted to rule out potential differences. Secondly, we acknowledge that we have split the cohort in three groups of patients based on an artificial definition reflecting our beliefs that the postoperative complications have to be analysed separately by categories to express a coherent pathogenic specific pathway rather than a grading system, such as Clavien classification where a mix of complications are analysed in terms of severity leading to difficult interpretations. This is likely to necessitate further investigations on this topic.
CONCLUSION
When postoperative 90-day mortality is excluded, postoperative respiratory complications do not affect cancer-specific survival in patients having received a complete resection for oesophageal cancer. This information is relevant to patients placed in critical situations and in whom salvage intensive care modalities are debated.
